Concerning the research of DR5 in gastric cancer, many of them mainly focused on the compounds' capability to sensitize TRAIL‐induced apoptosis by overexpression of DR5 or regulation of the TRAIL/DR5 pathway [28]. Here, TNFRSF10B is linked to gastric cancer.